Company
Qualigen Therapeutics
Description
Qualigen Therapeutics, Inc announced several board changes effective November 17, 2025. The Nominating and Governance Committee appointed Koti Meka, the Company’s Chief Financial Officer who also serves as CFO of Faraday Future Intelligent Electric Inc, as an Executive Director.
Quick answer
Qualigen Therapeutics, Inc. Appoints Koti Meka as Executive Director (November 20, 2025). Qualigen Therapeutics is based in Carlsbad, California, United States.
- What did Qualigen Therapeutics announce on November 20, 2025?
- Qualigen Therapeutics, Inc announced several board changes effective November 17, 2025. The Nominating and Governance Committee appointed Koti Meka, the Company’s Chief Financial Officer who also serves as CFO of Faraday Future Intelligent Electric Inc, as an Executive Director.
- What does Qualigen Therapeutics do?
- Qualigen Therapeutics, Inc. is a small-cap company facing challenges, including the need to regain compliance with NASDAQ's continued listing requirements.
- Where is Qualigen Therapeutics based?
- Qualigen Therapeutics is based in Carlsbad, California, United States.
- Which similar companies made leadership changes around the same time?
- NovaBridge (November 21, 2025), Nasus Pharma (November 20, 2025), OncoNano Medicine (November 17, 2025) and AdvanCell (November 17, 2025) also announced leadership changes within 45 days of Qualigen Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- NovaBridge's Visara Appoints Cadmus C. Rich as Chief Medical Officer (November 21, 2025)
- Nasus Pharma Appoints Eyal Rubin as Chief Financial Officer (November 20, 2025)
- OncoNano Appoints Brent Sorrells as Chief Operating Officer (November 17, 2025)
- AdvanCell Appoints Philina Lee as Chief Executive Officer (November 17, 2025)
- 4D Molecular Therapeutics Appoints Kristian Humer as Chief Financial Officer (November 17, 2025)
- Mosaic Therapeutics Appoints Dr Stephen Shuttleworth as Chief Scientific Officer (November 17, 2025)
Who to call at Qualigen Therapeutics, and when
A new leader at Qualigen Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Qualigen Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Qualigen Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Qualigen Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Qualigen Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Qualigen Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.